Drug Information

Drug General Information
Drug ID
D03PQH
Former ID
DNC014010
Drug Name
3-hydroxy-N,N,N-trimethylbenzenaminium iodide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529567]
Formula
C9H14INO
Canonical SMILES
C[N+](C)(C)C1=CC(=CC=C1)O.[I-]
InChI
1S/C9H13NO.HI/c1-10(2,3)8-5-4-6-9(11)7-8;/h4-7H,1-3H3;1H
InChIKey
KNPHMCQIKGHPRU-UHFFFAOYSA-N
PubChem Compound ID
17250
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [529567]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 529567Bioorg Med Chem. 2008 Aug 1;16(15):7450-6. Epub 2008 Jun 14.Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.
Ref 529567Bioorg Med Chem. 2008 Aug 1;16(15):7450-6. Epub 2008 Jun 14.Homo- and hetero-bivalent edrophonium-like ammonium salts as highly potent, dual binding site AChE inhibitors.